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Diuretic therapy has been the cornerstone of the medical treatment in patients 
with heart failure for the last fifty years. However, despite the fact that the majority of 
them are on diuretics, fluid balance remains a challenge for their physicians.1
Poor response, diuretic resistance, worsening of kidney function, electrolyte dis-
turbances, and diuretic therapy associated morbidity and mortality have stimulated 
interest to develop effective and safe treatment strategies that improve decongestion 
and preserve kidney function. Ultrafiltration has been used to remove fluid from 
diuretic-refractory hypervolemic patients. Recently clinical studies have suggested that 
ultrafiltration may be highly effective for decongesting patients with either chronic or 
acutely decompensated heart failure (ADHF).
Most patients admitted for ADHF have signs and symptoms of fluid, including 
dyspnea, weight gain, jugular venous distension, and peripheral and pulmonary edema. 
Current guidelines recommend the use of diuretics as first-line therapy. However 
registry data show that more than 20% of patients with ADHF admitted to hospitals 
do not lose weight.1
During the last twenty years, ultrafiltration using hemodialysis membranes and 
peritoneal dialysis has been used in diuretic-refractory patients with heart failure.8,9 
Several recent studies of patients with heart failure (SAFE,6 EUPHORIA,7 RAPID-
CHF,5 UNLOAD4,10) have compared the efficacy and safety of ultrafiltration versus 
diuretics. Most of them included patients with some degree of decreased kidney func-
tion, but excluded patients with severe renal dysfunction, hemodynamic instability, or 
lack of response to an aggressive diuretic regimen.
The advantages of ultrafiltration appears to be the decreased rehospitalization 
rate, the relatively higher sodium removal per mL of fluid removed, the controlled 
removal of volume, the avoidance of electrolyte derangements, the effectiveness in 
patients with diuretic resistance, the diminished long-term neurohormonal activation 
compared to diuretics and the possible restoration of diuretic responsiveness after 
diuretic holiday. However there are disadvantages like the systemic anticoagulation 
that was recommended by the operators, access-related complications (infection, 
bleeding), intravascular volume depletion, worsening of kidney function, lack of cost/
effectiveness studies and expertise in extracorporeal devices.3
The Task Force for the Diagnosis and Treatment of CHF of the European Society 
of Cardiology recommends the use of ultrafiltration in patients with coexisting kidney 
failure or hyponatremia and refractory to loop and thiazide diuretics. The ACC/AHA 
guidelines suggest the ultrafiltration in patients with acutely decompensated heart 
failure and decreased diuresis despite an increase in loop diuretic dose, addition of a 
second diuretic, or continuous infusion of a loop diuretic.2 An ongoing randomized 
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multicenter control trial, the Cardiorenal Rescue Study in 
Acute Decompensated Heart Failure (CARESS) will shed 
light to the riddle of the efficacy of ultrafiltration in patients 
with ADHF and cardiorenal syndrome.
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